PEG-SRLA blocks the effects of endogenous leptin but does not reduce or even aggravates other disturbances observed in obesity by reducing anorectic effect of leptin and further increasing weight gain. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.